Cell culture models to study retinal pigment epithelium-related pathogenesis in age-related macular degeneration
- PMID: 35835183
- PMCID: PMC9444976
- DOI: 10.1016/j.exer.2022.109170
Cell culture models to study retinal pigment epithelium-related pathogenesis in age-related macular degeneration
Abstract
Age-related macular degeneration (AMD) is a disease that affects the macula - the central part of the retina. It is a leading cause of irreversible vision loss in the elderly. AMD onset is marked by the presence of lipid- and protein-rich extracellular deposits beneath the retinal pigment epithelium (RPE), a monolayer of polarized, pigmented epithelial cells located between the photoreceptors and the choroidal blood supply. Progression of AMD to the late nonexudative "dry" stage of AMD, also called geographic atrophy, is linked to progressive loss of areas of the RPE, photoreceptors, and underlying choriocapillaris leading to a severe decline in patients' vision. Differential susceptibility of macular RPE in AMD and the lack of an anatomical macula in most lab animal models has promoted the use of in vitro models of the RPE. In addition, the need for high throughput platforms to test potential therapies has driven the creation and characterization of in vitro model systems that recapitulate morphologic and functional abnormalities associated with human AMD. These models range from spontaneously formed cell line ARPE19, immortalized cell lines such as hTERT-RPE1, RPE-J, and D407, to primary human (fetal or adult) or animal (mouse and pig) RPE cells, and embryonic and induced pluripotent stem cell (iPSC) derived RPE. Hallmark RPE phenotypes, such as cobblestone morphology, pigmentation, and polarization, vary significantly betweendifferent models and culture conditions used in different labs, which would directly impact their usability for investigating different aspects of AMD biology. Here the AMD Disease Models task group of the Ryan Initiative for Macular Research (RIMR) provides a summary of several currently used in vitro RPE models, historical aspects of their development, RPE phenotypes that are attainable in these models, their ability to model different aspects of AMD pathophysiology, and pros/cons for their use in the RPE and AMD fields. In addition, due to the burgeoning use of iPSC derived RPE cells, the critical need for developing standards for differentiating and rigorously characterizing RPE cell appearance, morphology, and function are discussed.
Keywords: ARPE19; Complement system; Organ-on-a-Chip; Primary cells; Retinal pigment epithelium; iPSC-RPE.
Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest Anneke is currently an employee of AbbVie.
References
-
- Achberger K, Probst C, Haderspeck J, Bolz S, Rogal J, Chuchuy J, Nikolova M, Cora V, Antkowiak L, Haq W, Shen N, Schenke-Layland K, Ueffing M, Liebau S, Loskill P. Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform. Elife 2019. Aug 27; 8: e46188. - PMC - PubMed
-
- Ahmado A, Carr AJ, Vugler AA, Semo M, Gias C, Lawrence JM, Chen LL, Chen FK, Turowski P, da Cruz L, Coffey PJ. Induction of differentiation by pyruvate and DMEM in the human retinal pigment epithelium cell line ARPE-19. Invest Ophthalmol Vis Sci 2011. Sep 9;52(10):7148–59. - PubMed
-
- Amin S, Chong NH, Bailey TA, Zhang J, Knupp C, Cheetham ME, Greenwood J, Luthert PJ. Modulation of Sub-RPE deposits in vitro: a potential model for age-related macular degeneration. Invest Ophthalmol Vis Sci 2004. May;45(5):1281–8. - PubMed
-
- An E, Lu X, Flippin J, Devaney JM, Halligan B, Hoffman EP, Strunnikova N, Csaky K, Hathout Y. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res 2006. Oct;5(10):2599–610. - PubMed
-
- Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010. Mar;29(2):95–112. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R01 EY028160/EY/NEI NIH HHS/United States
- R01 EY031594/EY/NEI NIH HHS/United States
- P30 EY005722/EY/NEI NIH HHS/United States
- P30 EY000331/EY/NEI NIH HHS/United States
- R01 EY031748/EY/NEI NIH HHS/United States
- ZIA EY000532/ImNIH/Intramural NIH HHS/United States
- R01 EY027442/EY/NEI NIH HHS/United States
- R01 EY030668/EY/NEI NIH HHS/United States
- R21 EY031109/EY/NEI NIH HHS/United States
- R01 EY032751/EY/NEI NIH HHS/United States
- R01 EY026215/EY/NEI NIH HHS/United States
- R01 EY026539/EY/NEI NIH HHS/United States
